Clinverse, Inc. and eClinical Insights announced today they have formed a strategic partnership.
Clinverse, Inc., the new standard for automating the financial lifecycle of global clinical trials, and eClinical Insights®, a leading-edge provider of cloud-based clinical trials software, announced today they have formed a strategic partnership.
Clinverse’s ClinPay® solution automates sponsor payments to clinical vendors, investigators, and other parties throughout the entire financial lifecycle of a clinical trial, reducing workload and costs while improving transparency and control. The eClinical Insights integrated technology platform delivers real-time visibility and control across disparate systems and diverse teams, providing actionable information through in-stream clinical trial intelligence and workflow capabilities.
“Together, we are able to offer CROs and clinical trial sponsors a best-of-breed, fully integrated solution that delivers real-time visibility across the eClinical ecosystem,” said Denis Connaghan, CEO of Clinverse. “Joint customers stand to gain a measureable return on investment, increased competitive advantage, and decreased ramp-up time and learning curve.”
Using the ClinPay application programming interface (API) and eClinical Insights proprietary integration framework, the integrated solution offers seamless data integration with any other clinical technology. With the financial lifecycle management of ClinPay and the combined trial management capabilities of eClinical Insights' TrialOps Director™ and inTrial Metrix™ applications, sponsors and CROs can further improve the performance of their clinical trials while substantially reducing labor costs associated with payment and accounting processes for clinical vendors and investigative sites.
“Adding Clinverse as a strategic partner in our integrated technology network enables us to expand the reach and capabilities of our platform,” said Peg Regan, President & CEO of eClinical Insights. “This partnership and integrated solution fit seamlessly with our philosophy and approach to improving trial performance across a complex eClinical ecosystem.”
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.